NLST
NLST, or the National Lung Screening Trial, was a large-scale clinical research study aimed at evaluating the effectiveness of low-dose computed tomography (LDCT) in screening for lung cancer. Conducted in the United States, the trial began in 2002 and was publicly announced in 2011 after its completion. It involved over 53,000 participants who were at high risk for lung cancer, primarily because of a history of heavy smoking.
The primary goal of NLST was to determine whether LDCT could reduce lung cancer mortality compared to
Results from NLST demonstrated a 20% reduction in lung cancer mortality among those screened with LDCT compared
The NLST has played a significant role in shaping lung cancer screening policies worldwide, leading to increased
Overall, the NLST has been a pivotal study in the field of cancer prevention and screening, providing